secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001842952-24-000087
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics sells 14.7M shares for ~$15M to MPM BioImpact
------------------------------------------------------------------

- Sold 14,705,882 shares at ~$1.02/share for aggregate gross proceeds of ~$15M.
- Shares purchased by MPM BioImpact LLC under sales agreement with Leerink Partners dated Dec 2, 2024.
- Proceeds expected to fund working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295224000087/0001842952-24-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295224000087/cntx-20241223.htm
  HTML page:      https://secwatch.observer/filing/0001842952-24-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer